Genome-wide association study of spontaneous resolution of hepatitis C virus infection: Data from multiple cohorts

Annals of Internal Medicine

Volumn 158, Issue 4, 2013, Pages 235-245

  Duggal, Priya ^a   Thio, Chloe L ^b   Wojcik, Genevieve L ^a   Goedert, James J ^c   Mangia, Alessandra ^d   Latanich, Rachel ^b   Kim, Arthur Y ^e   Lauer, Georg M ^e   Chung, Raymond T ^e   Peters, Marion G ^f   Kirk, Gregory D ^g   Mehta, Shruti H ^g   Cox, Andrea L ^b   Khakoo, Salim I ^h   Alric, Laurent ⁱ   Cramp, Matthew E ^j   Donfield, Sharyne M ^k   Edlin, Brian R ^l   Tobler, Leslie H ^m   Busch, Michael P ^m   Alexander, Graeme ⁿ   Rosen, Hugo R ^o   Gao, Xiaojiang ^p   Abdel Hamid, Mohamed ^q   Apps, Richard ^p   Carrington, Mary ^p   Thomas, David L ^b   more..

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^h IMPERIAL COLLEGE LONDON   (United Kingdom)

ⁱ INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^j PLYMOUTH HOSPITALS NHS TRUST   (United Kingdom)

^k not available   (United States)

^l WEILL CORNELL MEDICAL COLLEGE   (United States)

^m BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

ⁿ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^o UNIVERSITY OF COLORADO   (United States)

^p NATIONAL CANCER INSTITUTE   (United States)

^q Minia University   (Egypt)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874606648     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-158-4-201302190-00003     Document Type: Article

References (38)

1. Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ, et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science. 1998;282:103-7. [PMID: 9756471]
2. Villano SA, Vlahov D, Nelson KE, Cohn S, Thomas DL. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology. 1999;29:908-14. [PMID: 10051497]
3. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med. 1999;340:1228-33. [PMID: 10210705]
4. Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA. 2000;284:450-6. [PMID: 10904508]
5. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature. 2009; 461:798-801. [PMID: 19759533]
6. Rauch A, Kutalik Z, Descombes P, Cai T, Di Iulio J, Mueller T, et al; Swiss Hepatitis C Cohort Study. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology. 2010;138:1338-45, 1345.e1-7. [PMID: 20060832]
7. Hindorff LA, MacArthur J, Morales J, Junkins HA, Hall PN, Klemm AK, et al. A Catalog of Published Genome-Wide Association Studies. Accessed at www.genome.gov/gwastudies on 13 December 2012.
8. Vlahov D, Muñoz A, Anthony JC, Cohn S, Celentano DD, Nelson KE. Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland. Am J Epidemiol. 1990;132:847-56. [PMID: 2239899]
9. Cox AL, Netski DM, Mosbruger T, Sherman SG, Strathdee S, Ompad D, et al. Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clin Infect Dis. 2005;40:951-8. [PMID: 15824985]
10. Kim AY, Kuntzen T, Timm J, Nolan BE, Baca MA, Reyor LL, et al. Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes. Gastroenterology. 2011;140:686-696.e1. [PMID: 20875418]
11. Cramp ME, Carucci P, Underhill J, Naoumov NV, Williams R, Donaldson PT. Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia. J Hepatol. 1998;29:207-13. [PMID: 9722201]
12. Hilgartner MW, Donfield SM, Willoughby A, Contant CF Jr, Evatt BL, Gomperts ED, et al. Hemophilia growth and development study. Design, methods, and entry data. Am J Pediatr Hematol Oncol. 1993;15:208-18. [PMID: 8498644]
13. Mangia A, Gentile R, Cascavilla I, Margaglione M, Villani MR, Stella F, et al. HLA class II favors clearance of HCV infection and progression of the chronic liver damage. J Hepatol. 1999;30:984-9. [PMID: 10406174]
14. Goedert JJ, Chen BE, Preiss L, Aledort LM, Rosenberg PS. Reconstruction of the hepatitis C virus epidemic in the US hemophilia population, 1940-1990. Am J Epidemiol. 2007;165:1443-53. [PMID: 17379617]
15. Tobler LH, Bahrami SH, Kaidarova Z, Pitina L, Winkelman VK, Vanderpool SK, et al. A case-control study of factors associated with resolution of hepatitis C viremia in former blood donors (CME). Transfusion. 2010;50:1513-23. [PMID: 20345567]
16. Edlin BR, Shu MA, Winkelstein E, Des Jarlais DC, Busch MP, Rehermann B, et al. More rare birds, and the occasional swan [Letter]. Gastroenterology. 2009;136:2412-4. [PMID: 19414076]
17. Alric L, Fort M, Izopet J, Vinel JP, Charlet JP, Selves J, et al. Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection. Gastroenterology. 1997;113:1675-81. [PMID: 9352872]
18. Kuniholm MH, Gao X, Xue X, Kovacs A, Marti D, Thio CL, et al. The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women. J Infect Dis. 2011;203:1807-14. [PMID: 21606539]
19. Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, Astemborski J, et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science. 2004;305:872-4. [PMID: 15297676]
20. Dudbridge F, Gusnanto A. Estimation of significance thresholds for genomewide association scans. Genet Epidemiol. 2008;32:227-34. [PMID: 18300295]
21. Duggal P, Gillanders EM, Holmes TN, Bailey-Wilson JE. Establishing an adjusted p-value threshold to control the family-wide type 1 error in genome wide association studies. BMC Genomics. 2008;9:516. [PMID: 18976480]
22. So HC, Li M, Sham PC. Uncovering the total heritability explained by all true susceptibility variants in a genome-wide association study. Genet Epidemiol. 2011;35:447-56. [PMID: 21618601]
23. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559-75. [PMID: 17701901]
24. Marchini J, Howie B. Genotype imputation for genome-wide association studies. Nat Rev Genet. 2010;11:499-511. [PMID: 20517342]
25. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet. 2000;355:887-91. [PMID: 10752705]
26. Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet. 2006;38:209-13. [PMID: 16415888]
27. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature. 2009;461:399-401. [PMID: 19684573]
28. Fanning LJ, Levis J, Kenny-Walsh E, Whelton M, O'Sullivan K, Shanahan F. HLA class II genes determine the natural variance of hepatitis C viral load. Hepatology. 2001;33:224-30. [PMID: 11124840]
29. Kuniholm MH, Kovacs A, Gao X, Xue X, Marti D, Thio CL, et al. Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia. Hepatology. 2010;51:1514-22. [PMID: 20169624]
30. Thio CL, Thomas DL, Goedert JJ, Vlahov D, Nelson KE, Hilgartner MW, et al. Racial differences in HLA class II associations with hepatitis C virus outcomes. J Infect Dis. 2001;184:16-21. [PMID: 11398104]
31. Fellay J, Ge D, Shianna KV, Colombo S, Ledergerber B, Cirulli ET, et al; NIAID Center for HIV/AIDS Vaccine Immunology (CHAVI). Common genetic variation and the control of HIV-1 in humans. PLoS Genet. 2009;5: e1000791. [PMID: 20041166]
32. Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, Hosono N, et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet. 2009; 41:591-5. [PMID: 19349983]
33. Khor CC, Chau TN, Pang J, Davila S, Long HT, Ong RT, et al. Genomewide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1. Nat Genet. 2011;43:1139-41. [PMID: 22001756]
34. Rhodes SL, Erlich H, Im KA, Wang J, Li J, Bugawan T, et al; Virahep-C Study Group. Associations between the human MHC and sustained virologic response in the treatment of chronic hepatitis C virus infection. Genes Immun. 2008;9:328-33. [PMID: 18418397]
35. Schulze Zur Wiesch J, Ciuffreda D, Lewis-Ximenez L, Kasprowicz V, Nolan BE, Streeck H, et al. Broadly directed virus-specific CD4 T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence. J Exp Med. 2012;209:61-75. [PMID: 22213804]
36. Ghany MG, Strader DB, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009;49:1335-74. [PMID: 19330875]
37. Ray SC, Fanning L, Wang XH, Netski DM, Kenny-Walsh E, Thomas DL. Divergent and convergent evolution after a common-source outbreak of hepatitis C virus. J Exp Med. 2005;201:1753-9. [PMID: 15939791]
38. Timm J, Lauer GM, Kavanagh DG, Sheridan I, Kim AY, Lucas M, et al. CD8 epitope escape and reversion in acute HCV infection. J Exp Med. 2004; 200:1593-604. [PMID: 15611288]